Cray (CRAY): Tie Goes to the Company - Needham

Needham & Company analyst, Richard Keugele, reiterated his Buy rating on shares of Cray (NASDAQ: CRAY) after an in-line preannouncement removes the uncertainty that has continued to loom over CRAY’s Q4 results.

The analyst stated "We would be buyers on any weakness related to this in-line pre (consensus will likely be pulled in as some estimates were at the upper end of the guidance range, skewing consensus higher)."

No change to the price target of $25.00

For an analyst ratings summary and ratings history on Cray click here. For more ratings news on Cray click here.

Shares of Cray closed at $20.25 yesterday.

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Navitas to acquire Claros in a deal valued at up to $232.8M
• SK Hynix (SKHY) PT Raised to $220 at Needham